BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18701279)

  • 1. Synthesis of a C-glucosylated cyclopropylamide and evaluation as a glycogen phosphorylase inhibitor.
    Bertus P; Szymoniak J; Jeanneau E; Docsa T; Gergely P; Praly JP; Vidal S
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4774-8. PubMed ID: 18701279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 1-(D-glucopyranosyl)-1,2,3-triazoles and their evaluation as glycogen phosphorylase inhibitors.
    Bokor E; Docsa T; Gergely P; Somsák L
    Bioorg Med Chem; 2010 Feb; 18(3):1171-80. PubMed ID: 20080412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Glucosylated malonitrile as a key intermediate towards carbohydrate-based glycogen phosphorylase inhibitors.
    Feuillastre S; Chajistamatiou AS; Potamitis C; Zervou M; Zoumpoulakis P; Chrysina ED; Praly JP; Vidal S
    Bioorg Med Chem; 2012 Sep; 20(18):5592-9. PubMed ID: 22910227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
    Gregus Z; Németi B
    Toxicol Sci; 2007 Nov; 100(1):44-53. PubMed ID: 17693424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction.
    Baker DJ; Greenhaff PL; MacInnes A; Timmons JA
    Diabetes; 2006 Jun; 55(6):1855-61. PubMed ID: 16731853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of C-glycosylated oxadiazoles as inhibitors of glycogen phosphorylase.
    Tóth M; Kun S; Bokor E; Benltifa M; Tallec G; Vidal S; Docsa T; Gergely P; Somsák L; Praly JP
    Bioorg Med Chem; 2009 Jul; 17(13):4773-85. PubMed ID: 19450985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs.
    Oikonomakos NG; Kosmopoulou MN; Chrysina ED; Leonidas DD; Kostas ID; Wendt KU; Klabunde T; Defossa E
    Protein Sci; 2005 Jul; 14(7):1760-71. PubMed ID: 15987904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucopyranosylidene-spiro-iminothiazolidinone, a new bicyclic ring system: synthesis, derivatization, and evaluation for inhibition of glycogen phosphorylase by enzyme kinetic and crystallographic methods.
    Czifrák K; Páhi A; Deák S; Kiss-Szikszai A; Kövér KE; Docsa T; Gergely P; Alexacou KM; Papakonstantinou M; Leonidas DD; Zographos SE; Chrysina ED; Somsák L
    Bioorg Med Chem; 2014 Aug; 22(15):4028-41. PubMed ID: 25009003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes.
    Klabunde T; Wendt KU; Kadereit D; Brachvogel V; Burger HJ; Herling AW; Oikonomakos NG; Kosmopoulou MN; Schmoll D; Sarubbi E; von Roedern E; Schönafinger K; Defossa E
    J Med Chem; 2005 Oct; 48(20):6178-93. PubMed ID: 16190745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of N-(beta-D-glucopyranosyl) monoamides of dicarboxylic acids as potential inhibitors of glycogen phosphorylase.
    Czifrák K; Hadady Z; Docsa T; Gergely P; Schmidt J; Wessjohann L; Somsák L
    Carbohydr Res; 2006 Jun; 341(8):947-56. PubMed ID: 16564511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of N-(beta-D-glucopyranosyl)- and N-(2-acetamido-2-deoxy-beta-D-glucopyranosyl) amides as inhibitors of glycogen phosphorylase.
    Györgydeák Z; Hadady Z; Felföldi N; Krakomperger A; Nagy V; Tóth M; Brunyánszki A; Docsa T; Gergely P; Somsák L
    Bioorg Med Chem; 2004 Sep; 12(18):4861-70. PubMed ID: 15336265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis and modelling of the allosteric behaviour of liver and muscle glycogen phosphorylases.
    Cuadri-Tomé C; Barón C; Jara-Pérez V; Parody-Morreale A; Martinez JC; Cámara-Artigas A
    J Mol Recognit; 2006; 19(5):451-7. PubMed ID: 16691548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling aided design of potent glycogen phosphorylase inhibitors.
    Deng Q; Lu Z; Bohn J; Ellsworth KP; Myers RW; Geissler WM; Harris G; Willoughby CA; Chapman K; McKeever B; Mosley R
    J Mol Graph Model; 2005 Apr; 23(5):457-64. PubMed ID: 15781188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-(4-Substituted-benzoyl)-N'-(β-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods.
    Nagy V; Felföldi N; Kónya B; Praly JP; Docsa T; Gergely P; Chrysina ED; Tiraidis C; Kosmopoulou MN; Alexacou KM; Konstantakaki M; Leonidas DD; Zographos SE; Oikonomakos NG; Kozmon S; Tvaroška I; Somsák L
    Bioorg Med Chem; 2012 Mar; 20(5):1801-16. PubMed ID: 22325154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and glycogen phosphorylase inhibitory activity of N-(beta-D-glucopyranosyl)amides possessing 1,4-benzodioxane moiety.
    Czakó Z; Juhász L; Kenéz A; Czifrák K; Somsák L; Docsa T; Gergely P; Antus S
    Bioorg Med Chem; 2009 Sep; 17(18):6738-41. PubMed ID: 19703777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of substituted 2-(β-D-glucopyranosyl)-benzimidazoles and their evaluation as inhibitors of glycogen phosphorylase.
    Bokor É; Szilágyi E; Docsa T; Gergely P; Somsák L
    Carbohydr Res; 2013 Nov; 381():179-86. PubMed ID: 23419607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen phosphorylase a inhibitors with a phenethylphenylphthalimide skeleton derived from thalidomide-related alpha-glucosidase inhibitors and liver X receptor antagonists.
    Motoshima K; Ishikawa M; Sugita K; Hashimoto Y
    Biol Pharm Bull; 2009 Sep; 32(9):1618-20. PubMed ID: 19721243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological evaluation of bis-3-(3,4-dichlorophenyl)acrylamide derivatives as glycogen phosphorylase inhibitors.
    Onda K; Shiraki R; Yonetoku Y; Momose K; Katayama N; Orita M; Yamaguchi T; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2008 Sep; 16(18):8627-34. PubMed ID: 18723356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentacyclic triterpenes. Part 2: Synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors.
    Wen X; Zhang P; Liu J; Zhang L; Wu X; Ni P; Sun H
    Bioorg Med Chem Lett; 2006 Feb; 16(3):722-6. PubMed ID: 16246555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 2-(β-D-glucopyranosylamino)-5-substituted-1,3,4-oxadiazoles for inhibition of glycogen phosphorylase.
    Tóth M; Szőcs B; Kaszás T; Docsa T; Gergely P; Somsák L
    Carbohydr Res; 2013 Nov; 381():196-204. PubMed ID: 23673237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.